Treatment method does not improve survival for mantle cell lymphoma patients, clinical trial shows
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...
precisionmedicineonline13h
Adaptive Biotechnologies' MRD Test May Allow Some Mantle Cell Lymphoma Patients to Skip Transplant
A stem cell transplant added to Rituxan did not improve survival for MRD-negative MCL patients in their first remission ...